top of page
NoPalm Ingredients appoints Julie Cortal-Oosterveer as chief commercial officer

1 September 2025

NoPalm Ingredients appoints Julie Cortal-Oosterveer as chief commercial officer

NoPalm Ingredients has promoted Julie Cortal-Oosterveer to the role of chief commercial officer as the company accelerates its push toward industrialisation and commercialisation.

Protein Industries Canada CEO departs, board searching for new chief executive

28 August 2025

Protein Industries Canada CEO departs, board searching for new chief executive

Protein Industries Canada has announced that its CEO, Robert Hunter, is no longer with the organisation.

MycoTechnology appoints Robert Scott to board of directors

27 August 2025

MycoTechnology appoints Robert Scott to board of directors

US-based ingredient technology firm MycoTechnology has named Robert Scott to its board of directors.

Discovery Park expands biotech cluster with iLoF and MilaK arrivals

26 August 2025

Discovery Park expands biotech cluster with iLoF and MilaK arrivals

Discovery Park, Kent’s life sciences hub, has added two high-growth biotech start-ups to its CoLab innovation space.

Collateral Good takes over management of €100m sustainable food fund

22 August 2025

Collateral Good takes over management of €100m sustainable food fund

Sustainable investment firm Collateral Good has been appointed to manage a €100 million Sustainable Food Fund, formerly known as Blue Horizon Venture I.

The Good Food Institute appoints former Rainforest Alliance head Nigel Sizer as new CEO

21 August 2025

The Good Food Institute appoints former Rainforest Alliance head Nigel Sizer as new CEO

The Good Food Institute (GFI) has announced that Nigel Sizer – a climate and public health expert and former head of the Rainforest Alliance – will be joining as its new chief executive on 26 August.

The Better Meat Co raises $31m to scale mycoprotein fermentation

20 August 2025

The Better Meat Co raises $31m to scale mycoprotein fermentation

The Better Meat Co (BMC) has secured $31 million in an oversubscribed Series A funding round to expand its patented mycoprotein fermentation technology to commercial scale.

Corbion partners with Kuehnle AgroSystems to develop algae-derived astaxanthin

19 August 2025

Corbion partners with Kuehnle AgroSystems to develop algae-derived astaxanthin

Corbion has entered a strategic partnership with US biotech company Kuehnle AgroSystems (KAS) to develop and commercialise a natural astaxanthin product made from non-GMO heterotrophic algae.

  • Page 6
Alternative Proteins

LATEST NEWS

Alternative Proteins
bottom of page